MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and other
comprehensive loss for the year
-$40,287K
(-31.49%↓ Y/Y)
Foreign currency
translation adjustment
$2,283K
(180.87%↑ Y/Y)
US
$8,095K
(25.35%↑ Y/Y)
CA
$862K
(-3.25%↓ Y/Y)
DE
$773K
US
$4,150K
(365.25%↑ Y/Y)
CA
$2,218K
(43.28%↑ Y/Y)
Net loss attributed
to shareholders...
-$42,570K
(-53.04%↓ Y/Y)
Recurring non capital
$9,730K
(18.08%↑ Y/Y)
Capital Equipment
$6,368K
(160.98%↑ Y/Y)
Net loss before
income taxes
-$42,318K
(-52.12%↓ Y/Y)
Total income tax
(recovery) expense
$252K
(12700.00%↑ Y/Y)
Revenue
$16,098K
(50.73%↑ Y/Y)
Operating loss
-$41,254K
(-24.78%↓ Y/Y)
Total other (income)
expenses
-$1,064K
(-120.29%↓ Y/Y)
Income tax expense
(note 13)
$231K
(60.42%↑ Y/Y)
Deferred tax (recovery)
expense (note 13)
$21K
(114.38%↑ Y/Y)
Gross profit
$11,393K
(61.90%↑ Y/Y)
Net finance
(income) expense
$1,070K
(-25.49%↓ Y/Y)
Cost of sales
$4,705K
(29.15%↑ Y/Y)
Total operating
expenses
$52,647K
(31.29%↑ Y/Y)
Net foreign
exchange (gain) loss
-$2,134K
(-156.04%↓ Y/Y)
Selling, general and
administrative
$32,051K
(38.54%↑ Y/Y)
Research and development
$20,596K
(21.40%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)